Cyclacel Pharmaceuticals's total assets for Q2 2024 were $8.19M, an increase of 32.85% from the previous quarter. CYCC total liabilities were $7.19M for the fiscal quarter, a -14.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.